Home › Asset managers › Compare 2025-2026 › Vanguard vs John Hancock
Vanguard 2025-2026 · John Hancock 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 24,250 | 20,523 | 1,067 | 2,660 | 95.1% | 91.3% |
| Board proposals | 19,946 | 16,805 | 965 | 2,176 | 94.6% | 90.9% |
| E&S shareholder proposals | 163 | 81 | 5 | 77 | 94.2% | 82.9% |
| Other items | 4,141 | 3,637 | 97 | 407 | 97.4% | 93.7% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
2,176 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Vanguard | John Hancock |
|---|---|---|---|---|---|---|
| ATLAS COPCO AB | April 28, 2026 | REELECT PETER WALLENBERG JR AS DIRECTOR Director Elections |
Board | For | Split 4 FOR, 7 AGAINST |
Split 2 FOR, 3 AGAINST |
| ATLASSIAN CORPORATION | December 2, 2025 | Approval of an amendment and restatement to our 2015 Employee Share Purchase Plan. Compensation |
Board | For | Split 18 FOR, 8 AGAINST |
AGAINST 2 funds |
| ATN INTERNATIONAL, INC. | June 16, 2026 | To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent auditor for the fiscal year ending December 31, 2026. Audit-related |
Board | For | Split 8 FOR, 1 AGAINST |
FOR 4 funds |
| ATOMERA INCORPORATED | May 12, 2026 | To approve and adopt an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the Corporation's authorized common stock to 95 million shares. Capital Structure |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 1 fund |
| ATYR PHARMA, INC | May 11, 2026 | To approve an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 170,000,000 to 340,000,000 shares; Capital Structure |
Board | For | Split 7 FOR, 1 AGAINST |
FOR 2 funds |
| AURORA INNOVATION, INC. | May 21, 2026 | Election of Directors Gloria Boyland Director Elections |
Board | For | FOR 1 fund |
Split 2 FOR, 3 WITHHOLD |
| AURORA INNOVATION, INC. | May 21, 2026 | Election of Directors Michelangelo Volpi Director Elections |
Board | For | FOR 1 fund |
Split 3 FOR, 2 WITHHOLD |
| AUTODESK, INC. | June 17, 2026 | Election of Directors Blake Irving Director Elections |
Board | For | FOR 1 fund |
Split 5 FOR, 1 AGAINST |
| AUTODESK, INC. | June 17, 2026 | Ratify the appointment of Ernst & Young LLP as Autodesk, Inc.'s independent registered public accounting firm for the fiscal year ending January 31, 2027. Audit-related |
Board | For | Split 42 FOR, 1 AGAINST |
FOR 6 funds |
| AUTOLIV, INC. | May 7, 2026 | Election of Directors: Jan Carlson Director Elections |
Board | For | Split 8 FOR, 1 WITHHOLD |
FOR 6 funds |
| AUTOZONE, INC. | December 17, 2025 | Approval of an advisory vote on the compensation of named executive officers Say-on-Pay |
Board | For | FOR 35 funds |
Split 13 FOR, 1 AGAINST |
| AUTOZONE, INC. | December 17, 2025 | Election of Directors: Michael A. George Director Elections |
Board | For | FOR 28 funds |
Split 10 FOR, 1 AGAINST |
| AUTOZONE, INC. | December 17, 2025 | Election of Directors: William C. Rhodes, III Director Elections |
Board | For | FOR 28 funds |
Split 10 FOR, 1 AGAINST |
| AUTOZONE, INC. | December 17, 2025 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year Audit-related |
Board | For | Split 36 FOR, 1 AGAINST |
FOR 11 funds |
| AVALO THERAPEUTICS, INC. | June 2, 2026 | To approve the Avalo Therapeutics, Inc. Second Amended and Restated 2016 Employee Stock Purchase Plan; Compensation |
Board | For | Split 3 FOR, 1 AGAINST |
AGAINST 1 fund |
| AVALONBAY COMMUNITIES, INC. | May 20, 2026 | To adopt a resolution approving, on a non-binding advisory basis, the compensation paid to the Company's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and any related material disclosed in the proxy statement. Say-on-Pay |
Board | For | Split 28 FOR, 7 AGAINST |
FOR 9 funds |
| AVANOS MEDICAL,INC. | April 21, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 26 funds |
Split 6 FOR, 1 AGAINST |
| AVANOS MEDICAL,INC. | April 21, 2026 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026. Audit-related |
Board | For | Split 16 FOR, 4 AGAINST |
FOR 5 funds |
| AVEANNA HEALTHCARE HOLDINGS INC. | May 29, 2026 | To approve, on an advisory, non-binding, basis, the compensation paid to the Company's Named Executive Officers identified in the accompanying Proxy Statement. Say-on-Pay |
Board | For | Split 20 FOR, 1 AGAINST |
AGAINST 5 funds |
| AVERY DENNISON CORPORATION | April 30, 2026 | Ratification of the appointment of PwC as our independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | Split 25 FOR, 9 AGAINST |
FOR 9 funds |
| AVIDITY BIOSCIENCES, INC. | February 26, 2026 | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers in connection with the transactions contemplated by the Merger Agreement and the Separation Agreement. Say-on-Pay |
Board | For | Split 18 FOR, 1 AGAINST |
Split 5 FOR, 1 AGAINST |
| AVOLTA AG | May 6, 2026 | Approve Remuneration Report (Non-Binding) Say-on-Pay |
Board | For | FOR 5 funds |
Split 3 FOR, 1 AGAINST |
| AVOLTA AG | May 6, 2026 | Reelect Ranjan Sen as Director Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 AGAINST |
| AVOLTA AG | May 6, 2026 | Reelect Sami Kahale as Director Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 AGAINST |
| AXIS BANK LTD | July 25, 2025 | BORROWING / RAISING OF FUNDS IN INDIAN RUPEES / FOREIGN CURRENCY, BY ISSUE OF DEBT SECURITIES ON A PRIVATE PLACEMENT BASIS FOR AN AMOUNT OF UP TO RS. 35,000 CRORES Capital Structure |
Board | For | FOR 1 fund |
Split 2 FOR, 1 AGAINST |
| AXIS BANK LTD | July 25, 2025 | ENHANCEMENT OF BORROWING LIMIT OF THE BANK UP TO RS. 3,00,000 CRORES UNDER SECTION 180 (1)(C) OF THE COMPANIES ACT, 2013 Capital Structure |
Board | For | FOR 1 fund |
Split 2 FOR, 1 AGAINST |
| AXON ENTERPRISE, INC. | May 28, 2026 | Election of nine directors of the Company named in the proxy statement. Adriane Brown Director Elections |
Board | For | FOR 1 fund |
Split 8 FOR, 1 AGAINST |
| AXON ENTERPRISE, INC. | May 28, 2026 | Election of nine directors of the Company named in the proxy statement. Erika Ayers Badan Director Elections |
Board | For | FOR 1 fund |
Split 8 FOR, 1 AGAINST |
| AXON ENTERPRISE, INC. | May 28, 2026 | Election of nine directors of the Company named in the proxy statement. Graham Smith Director Elections |
Board | For | FOR 1 fund |
Split 8 FOR, 1 AGAINST |
| AXON ENTERPRISE, INC. | May 28, 2026 | Election of nine directors of the Company named in the proxy statement. Hadi Partovi Director Elections |
Board | For | FOR 1 fund |
Split 8 FOR, 1 AGAINST |
| AXON ENTERPRISE, INC. | May 28, 2026 | Election of nine directors of the Company named in the proxy statement. Michael Garnreiter Director Elections |
Board | For | FOR 1 fund |
Split 4 FOR, 5 AGAINST |
| AXON ENTERPRISE, INC. | May 28, 2026 | Proposal No. 2 requests that shareholders vote to approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 45 funds |
Split 11 FOR, 1 AGAINST |
| AXOS FINANCIAL, INC. | November 13, 2025 | To approve in a non-binding and advisory vote, the compensation of the Company's Named Executive Officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | Split 22 FOR, 1 AGAINST |
AGAINST 7 funds |
| AXT, INC. | June 4, 2026 | To approve an amendment to the Company's Restated Certificate of Incorporation, as amended, to increase the total number of authorized shares of common stock, par value $0.001 per share, from 70,000,000 to 120,000,000 in substantially the form attached to the Proxy Statement as Appendix A (the ''Amendment Proposal''). Capital Structure |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 2 funds |
| AZENTA, INC. | January 28, 2026 | To approve by a non-binding advisory vote the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 21 FOR, 2 AGAINST |
FOR 6 funds |
| AZRIELI GROUP LTD | August 7, 2025 | REELECT DAN YITZHAK GILLERMAN AS DIRECTOR Director Elections |
Board | For | FOR 6 funds |
Split 3 FOR, 1 AGAINST |
| AZRIELI GROUP LTD | August 7, 2025 | REELECT NECHEMIA JACOB PERES AS DIRECTOR Director Elections |
Board | For | FOR 6 funds |
Split 3 FOR, 1 AGAINST |
| AZRIELI GROUP LTD | August 7, 2025 | REELECT VARDA LEVY AS EXTERNAL DIRECTOR Director Elections |
Board | For | FOR 6 funds |
Split 3 FOR, 1 AGAINST |
| Advantage Solutions Inc. | May 27, 2026 | To approve, on an advisory (non-binding) basis, the compensation of the Advantage Solutions Inc.'s named executive officers. Say-on-Pay |
Board | For | Split 9 FOR, 1 AGAINST |
AGAINST 1 fund |
| Altimmune, Inc. | September 25, 2025 | Hold an advisory vote on compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. Say-on-Pay |
Board | For | Split 13 FOR, 1 AGAINST |
AGAINST 2 funds |
| Apartment Investment and Management Company | February 6, 2026 | Compensation Proposal. To approve, on a non-binding, advisory basis, the specified compensation that may be paid or become payable to Aimco's named executive officers in connection with the Plan of Sale and Liquidation. Say-on-Pay |
Board | For | Split 11 FOR, 9 AGAINST |
AGAINST 2 funds |
| B. RILEY FINANCIAL, INC. | December 1, 2025 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 6 FOR, 1 AGAINST |
AGAINST 2 funds |
| B2GOLD CORP | June 4, 2026 | ADVISORY VOTE ON EXECUTIVE COMPENSATION APPROACH Say-on-Pay |
Board | For | FOR 5 funds |
Split 1 FOR, 1 AGAINST |
| BAKKT, INC. | June 23, 2026 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | Split 11 FOR, 1 AGAINST |
FOR 5 funds |
| BALLY'S CORPORATION | May 19, 2026 | Approve an amendment and restatement of the Bally's Corporation Amended and Restated 2021 Equity Incentive Plan. Compensation |
Board | For | Split 6 FOR, 1 AGAINST |
AGAINST 2 funds |
| BALLY'S CORPORATION | May 19, 2026 | Approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 5 FOR, 4 AGAINST |
AGAINST 4 funds |
| BALLY'S CORPORATION | May 19, 2026 | Ratification of the appointment of independent registered public accounting firm. Audit-related |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 2 funds |
| BANC OF CALIFORNIA, INC. | May 6, 2026 | Approval, on an advisory and non-binding basis, of the compensation paid to the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. Say-on-Pay |
Board | For | FOR 28 funds |
Split 6 FOR, 1 AGAINST |
| BANDWIDTH INC. | May 28, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement; Say-on-Pay |
Board | For | Split 17 FOR, 1 AGAINST |
AGAINST 6 funds |
| BANK FIRST CORPORATION | June 15, 2026 | To elect three (3) directors of the Corporation, each for three-year terms and in each case until their successors are elected and qualified; STEVEN M. ELDRED Director Elections |
Board | For | FOR 10 funds |
Split 3 FOR, 1 WITHHOLD |
| BANK OF AMERICA CORPORATION | May 4, 2026 | Approving our executive compensation (an advisory, non- binding "Say on Pay" resolution) Say-on-Pay |
Board | For | Split 41 FOR, 10 AGAINST |
FOR 3 funds |
| BANK OF HAWAII CORPORATION | April 24, 2026 | Say on Pay - An advisory vote on executive compensation. Say-on-Pay |
Board | For | Split 30 FOR, 1 AGAINST |
AGAINST 6 funds |
| BANKUNITED, INC. | May 21, 2026 | Advisory vote to approve the compensation of the Company's named executive officers; and Say-on-Pay |
Board | For | FOR 27 funds |
Split 6 FOR, 2 AGAINST |
| BANKUNITED, INC. | May 21, 2026 | To approve the BankUnited, Inc. Amended and Restated 2023 Omnibus Equity Incentive Plan. Compensation |
Board | For | FOR 30 funds |
Split 1 FOR, 5 AGAINST |
| BANQUE CANTONALE VAUDOISE | April 30, 2026 | APPROVE LONG-TERM VARIABLE REMUNERATION OF EXECUTIVE COMMITTEE IN FORM OF 9,952 SHARES Compensation |
Board | For | Split 7 FOR, 1 AGAINST |
AGAINST 4 funds |
| BATH & BODY WORKS, INC. | June 11, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | Split 27 FOR, 6 AGAINST |
FOR 8 funds |
| BAXTER INTERNATIONAL INC. | May 5, 2026 | Advisory Vote to Approve Named Executive Officer Compensation for 2025 Say-on-Pay |
Board | For | Split 26 FOR, 7 AGAINST |
Split 8 FOR, 2 AGAINST |
| BAXTER INTERNATIONAL INC. | May 5, 2026 | Approval of the Baxter International Inc. Second Amended and Restated 2021 Incentive Plan Compensation |
Board | For | FOR 29 funds |
Split 1 FOR, 6 AGAINST |
| BAYCOM CORP | June 16, 2026 | An advisory (non-binding) vote on executive compensation. Say-on-Pay |
Board | For | FOR 10 funds |
Split 4 FOR, 3 AGAINST |
| BAYCOM CORP | June 16, 2026 | To elect nine (9) directors to serve as members of the Board of Directors of the Company, each for a one-year term Bhupen B. Amin Director Elections |
Board | For | FOR 6 funds |
Split 3 FOR, 2 WITHHOLD |
| BCB BANCORP, INC. | April 23, 2026 | Election of Directors: James Rizzo Director Elections |
Board | For | FOR 6 funds |
Split 2 FOR, 1 WITHHOLD |
| BCB BANCORP, INC. | April 23, 2026 | Election of Directors: Michael Widmer Director Elections |
Board | For | FOR 6 funds |
Split 2 FOR, 1 WITHHOLD |
| BCB BANCORP, INC. | April 23, 2026 | Election of Directors: Ryan Blake Director Elections |
Board | For | FOR 6 funds |
Split 2 FOR, 1 WITHHOLD |
| BEACON FINANCIAL CORPORATION | May 13, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 26 FOR, 1 AGAINST |
AGAINST 6 funds |
| BED BATH & BEYOND, INC. | May 14, 2026 | The ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | Split 9 FOR, 2 AGAINST |
FOR 3 funds |
| BEIJER REF AB | April 23, 2026 | APPROVE ALTERNATIVE EQUITY PLAN FINANCING OF LTI 2026, IF ITEM 15.B IS NOT APPROVED Compensation |
Board | For | FOR 7 funds |
Split 1 FOR, 2 AGAINST |
| BEIJER REF AB | April 23, 2026 | APPROVE EQUITY PLAN FINANCING THROUGH ACQUISITION AND TRANSFER OF SHARES Compensation |
Board | For | FOR 7 funds |
Split 1 FOR, 2 AGAINST |
| BEIJER REF AB | April 23, 2026 | APPROVE PERFORMANCE SHARE MATCHING PLAN LTI 2026 FOR KEY EMPLOYEES Compensation |
Board | For | FOR 7 funds |
Split 1 FOR, 2 AGAINST |
| BEIJER REF AB | April 23, 2026 | APPROVE REMUNERATION REPORT Say-on-Pay |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 3 funds |
| BEIJER REF AB | April 23, 2026 | ELECT PER BERTLAND AS BOARD CHAIR Corporate Governance |
Board | For | Split 1 FOR, 6 AGAINST |
AGAINST 3 funds |
| BEIJER REF AB | April 23, 2026 | REELECT ALBERT GUSTAFSSON AS DIRECTOR Director Elections |
Board | For | Split 1 FOR, 6 AGAINST |
AGAINST 3 funds |
| BEIJER REF AB | April 23, 2026 | REELECT JOEN MAGNUSSON AS DIRECTOR Director Elections |
Board | For | FOR 7 funds |
Split 1 FOR, 2 AGAINST |
| BEIJER REF AB | April 23, 2026 | REELECT PER BERTLAND AS DIRECTOR Director Elections |
Board | For | Split 1 FOR, 6 AGAINST |
AGAINST 3 funds |
| BELLRING BRANDS, INC. | January 28, 2026 | Election of Directors: Robert V. Vitale Director Elections |
Board | For | Split 7 FOR, 10 WITHHOLD |
FOR 9 funds |
| BELLRING BRANDS, INC. | January 28, 2026 | To consider and vote, on an advisory basis, for the adoption of a resolution approving the compensation of our named executive officers, as such compensation is described under the "Compensation Discussion and Analysis" and "Executive Compensation" sections of this proxy statement. Say-on-Pay |
Board | For | Split 23 FOR, 1 AGAINST |
Split 10 FOR, 1 AGAINST |
| BELLWAY PLC | November 27, 2025 | AUTHORISE ISSUE OF EQUITY WITHOUT PRE-EMPTIVE RIGHTS IN CONNECTION WITH AN ACQUISITION OR OTHER CAPITAL INVESTMENT Capital Structure |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 2 funds |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | Election of Directors: Barry J. Bentley Director Elections |
Board | For | FOR 15 funds |
Split 1 FOR, 7 WITHHOLD |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | Election of Directors: Gregory S. Bentley Director Elections |
Board | For | FOR 15 funds |
Split 1 FOR, 7 WITHHOLD |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | Election of Directors: Keith A. Bentley Director Elections |
Board | For | FOR 15 funds |
Split 1 FOR, 7 WITHHOLD |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | Election of Directors: Nicholas H. Cumins Director Elections |
Board | For | FOR 15 funds |
Split 1 FOR, 7 WITHHOLD |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | Election of Directors: Raymond B. Bentley Director Elections |
Board | For | FOR 15 funds |
Split 1 FOR, 7 WITHHOLD |
| BERKSHIRE HATHAWAY INC. | May 2, 2026 | Non-binding resolution to approve the compensation of the Company's Named Executive Officers, as described in the 2026 Proxy Statement. Say-on-Pay |
Board | For | Split 29 FOR, 1 AGAINST |
AGAINST 10 funds |
| BEST BUY CO., INC. | June 12, 2026 | To approve in a non-binding advisory vote our named executive officer compensation Say-on-Pay |
Board | For | Split 29 FOR, 7 AGAINST |
FOR 12 funds |
| BETTER HOME & FINANCE HOLDING COMPANY | June 10, 2026 | Ratification of the appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | Split 8 FOR, 2 AGAINST |
FOR 3 funds |
| BEYOND MEAT, INC. | May 20, 2026 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | Split 8 FOR, 2 AGAINST |
FOR 5 funds |
| BEYOND MEAT, INC. | May 20, 2026 | To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 1 FOR, 13 AGAINST |
AGAINST 7 funds |
| BGC GROUP INC. | November 12, 2025 | Approval, on an advisory basis, of executive compensation. Say-on-Pay |
Board | For | Split 27 FOR, 1 AGAINST |
AGAINST 6 funds |
| BICARA THERAPEUTICS INC. | June 9, 2026 | To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal. Christopher Bowden, M.D. Director Elections |
Board | For | FOR 9 funds |
Split 2 FOR, 3 WITHHOLD |
| BIGBEAR.AI HOLDINGS, INC. | April 21, 2026 | To approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock of the Company from 500,000,000 to 1,000,000,000. Capital Structure |
Board | For | Split 10 FOR, 2 AGAINST |
FOR 3 funds |
| BILL HOLDINGS, INC. | December 11, 2025 | To approve, on an advisory basis, the compensation of our Named Executive Officers (Say-on-Pay). Say-on-Pay |
Board | For | Split 24 FOR, 1 AGAINST |
FOR 7 funds |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Nominees: Arnold A. Pinkston Director Elections |
Board | For | FOR 17 funds |
Split 8 FOR, 1 AGAINST |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Nominees: Melinda Litherland Director Elections |
Board | For | FOR 17 funds |
Split 8 FOR, 1 AGAINST |
| BIO-TECHNE CORP | October 30, 2025 | Approve, on an advisory basis, the compensation of our executive officers. Say-on-Pay |
Board | For | Split 27 FOR, 1 AGAINST |
AGAINST 9 funds |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. Compensation |
Board | For | Split 17 FOR, 3 AGAINST |
AGAINST 3 funds |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To hold a non-binding, advisory vote regarding executive compensation. Say-on-Pay |
Board | For | Split 24 FOR, 1 AGAINST |
AGAINST 5 funds |
| BIOHAVEN LTD | April 28, 2026 | A non-binding advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 17 FOR, 3 AGAINST |
FOR 6 funds |
| BIOHAVEN LTD | April 28, 2026 | Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan Director Elections |
Board | For | Split 11 FOR, 1 AGAINST |
Split 1 FOR, 3 AGAINST |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | Split 30 FOR, 8 AGAINST |
Split 6 FOR, 3 AGAINST |
| BIOMERIEUX SA | May 28, 2026 | APPROVE COMPENSATION OF ALEXANDRE MERIEUX, CHAIRMAN OF THE BOARD Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 1 AGAINST |
| BIOMERIEUX SA | May 28, 2026 | APPROVE COMPENSATION REPORT OF CORPORATE OFFICERS Compensation |
Board | For | FOR 6 funds |
Split 1 FOR, 3 AGAINST |
← Previous Page 3 of 22 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.